Lyng, H
155  Ergebnisse:
Personensuche X
?
1

SP-0188 Mechanisms underlying immune suppression by hypoxia..:

Lyng, H.
Radiotherapy and Oncology.  182 (2023)  - p. S137 , 2023
 
?
2

OC-0091 An immune gene expression risk score for distant me..:

Lukovic, J. ; Pintilie, M. ; Han, K....
Radiotherapy and Oncology.  182 (2023)  - p. S54-S55 , 2023
 
?
 
?
4

SP-0956 How can omics lead to personalised radiation oncolo..:

Lyng, H.
Radiotherapy and Oncology.  170 (2022)  - p. S847 , 2022
 
?
5

OC-0280 Tumour hypoxia and immunity as predictors of chemor..:

Fjeldbo, C. ; Skingen, V.E. ; Aarnes, E...
Radiotherapy and Oncology.  161 (2021)  - p. S189-S190 , 2021
 
?
 
?
7

PO-1922 Classification of prostate cancer by hypoxia-relate..:

Skingen, V.E. ; Hompland, T. ; Salberg, U.B....
Radiotherapy and Oncology.  161 (2021)  - p. S1639-S1640 , 2021
 
?
9

PH-0442 Risk of recurrence identified by MRI and FDG-PET in..:

Skipar, K. ; Hompland, T. ; Lund, K.V....
Radiotherapy and Oncology.  161 (2021)  - p. S341-S342 , 2021
 
?
 
?
11

SP-0548: Genomic biomarkers for selection of patients to hy..:

Lyng, H.
Radiotherapy and Oncology.  127 (2018)  - p. S291 , 2018
 
?
 
?
13

SP-0492: Genomics and imaging: a pas-de-deaux in response p..:

Lyng, H.
Radiotherapy and Oncology.  119 (2016)  - p. S234 , 2016
 
?
 
1-15